In data analysis on the Oncomine® platform from patients with CRC, a decreased expression of inflammasome NLRP1, NLRP3, NLRC4, and AIM2 was observed compared to healthy controls (114). The gene discussed is NLRP3; the disease is colorectal carcinoma.